我院2012年冠心病患者血清胆红素检测结果分析

目的：探讨冠心病患者血清胆红素水平变化在临床诊断中的意义及应用价值。方法检测50例急性心肌梗死（AMI）组、50例不稳定型心绞痛（UAP）组、50例稳定型心绞痛（SAP）组以及50例健康对照组总胆红素（TBIL）、直接胆红素（DBIL）和间接胆红素（IBIL）含量,同时分析它们间的关系。结果冠心病各组的TBIL、DBIL和IBIL与对照组比较均显著降低,差异有统计学意义（P〈0.05）;其中AMI组的TBIL与UAP组、SAP组比较,有所升高,差异有统计学意义（P〈0.01）,冠心病各组之间的DBIL、IBIL检测结果相互比较差异无统计学意义（P〉0.05）。结论检测冠心病患者血清胆红素水平对预测评估冠心病有一定临床价值。

Analysis of the significance of bilirubin testing in our hospital patients with coronary heart disease during 2012

Objective To investigate the significance of bilirubin testing in patients with coronary heart disease. Methods A total of 150 patients with coronary heart disease who received, they were divided into three groups：AMI group, UAP group and SAP group, and 50 healthy persons who served as control group. The screening Methods included Total Bilirubin （TBIL）, Direct Bilirubin （DBIL） and Indirect Bilirubin （IBIL） test. Results Serum TBIL, DBIL and IBIL level was significantly lower in cases with coronary heart disease group than that of control group （P〈0.05）, but AMI group’s serum TBIL level was significantly higher than UAP group and SAP group （P〈0.01）. Serum DBIL and IBIL level was no different among AMI group, UAP group and SAP group（P＆gt;0.05）. Conclusion The serum bilirubin is an potential effective substance in the prevention of coronary heart disease, so it’s testing in patients with coronary heart disease is of great significance.